首页> 外文期刊>Surgery >Predictive factors for recurrence after thyroid lobectomy for unilateral non-toxic goiter in an endemic area: results of a multivariate analysis.
【24h】

Predictive factors for recurrence after thyroid lobectomy for unilateral non-toxic goiter in an endemic area: results of a multivariate analysis.

机译:单侧无毒甲状腺肿在甲状腺叶切除术后复发的预测因素:多因素分析的结果。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The aim of the study was to identify the factors that are predictive of recurrence after thyroid lobectomy for unilateral non-toxic thyroid goiter in an endemic region through a multivariate analysis. METHODS: Two hundred sixty-eight consecutive patients who underwent thyroid lobectomy and who were evaluated by the same endocrinologist were included. Univariate and multivariate analysis analyzed the relationship between sex, age, preoperative thyroid-stimulating hormone, duration of disease, duration of levothyroxine (LT4) preoperative therapy, cytologic results, histologic results, resected thyroid weight, numbers and diameters of thyroid nodules, morphologic alterations of the remnant lobe, follow-up length, postoperative LT4 therapy, ultrasonographic evidence of recurrence, and reoperation. RESULTS: The incidence of recurrence was 33.9% (91/268 patients) after a mean follow-up time of 79.9 months (range, 12-251 months), female sex ( P = .016), multiple nodules ( P = .017), and lack of postoperative LT4 therapy ( P = .0009) were predictive factors of recurrence. Reoperation was performed in 20 patients (7.4%); factors that were predictive of reoperation were the presence of multiple nodules ( P = .008), resected thyroid weight ( P = .00006), and lack of postoperative hormonal therapy ( P = .0005). CONCLUSIONS: Thyroid lobectomy for unilateral non-toxic goiter, when combined with suppressive or substitutive thyroxin therapy, resulted in a low rate of recurrence and reoperation in an endemic area.
机译:摘要背景:这项研究的目的是通过多变量分析确定流行性地区单侧无毒甲状腺甲状腺肿在甲状腺叶切除术后复发的预测因素。方法:纳入了268例接受甲状腺叶切除术并由同一内分泌科医生进行评估的连续患者。单因素和多因素分析分析了性别,年龄,术前促甲状腺激素,疾病持续时间,左甲状腺素(LT4)术前治疗持续时间,细胞学结果,组织学结果,切除的甲状腺重量,甲状腺结节的数量和直径,形态学改变之间的关系。残叶,随访时间,术后LT4治疗,超声检查是否复发和再次手术。结果:平均随访时间为79.9个月(范围为12-251个月),女性(P = .016),多发结节(P = .017),复发率为33.9%(91/268例)。 )和缺乏术后LT4治疗(P = .0009)是复发的预测因素。 20例患者(7.4%)再次手术;可以预测再次手术的因素是多个结节的存在(P = 0.008),切除的甲状腺重量(P = 0.000000)和缺乏术后激素治疗(P = 0.0005)。结论:单侧无毒性甲状腺肿大的甲状腺叶切除术,与抑制性或替代性甲状腺素治疗相结合,在地方性地区的复发率和再次手术率较低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号